Safety and efficacy of a mutagen-attenuated Rift valley fever virus vaccine in cattle

American Journal of Veterinary Research

Volumn 58, Issue 10, 1997, Pages 1104-1109

  Morrill, J C ^a,d   Mebus, C A ^b   Peters, C J ^c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d DOD Veterinary Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COW; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEMORRHAGIC FEVER; IMMUNE RESPONSE; LACTATION; NONHUMAN; RIFT VALLEY FEVER BUNYAVIRUS; VACCINATION; VERTICAL TRANSMISSION; VIREMIA; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; LACTATION DISORDERS; MALE; MUTAGENS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RISK FACTORS; SAFETY; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0030874805     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Meegan JM, Hoogstral H, Moussa MI. An epizootic of Rift Valley fever virus in Egypt in 1977. Vet Rec 1979;105:124-125.
2. Arthur RR, Said El-Sharkawy M, Cope SE, et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993;342:1149-1150.
3. Morvan J, Rollin PE, Laventure S, et al. Rift Valley fever epizootic in the central highlands of Madagascar. Res Virol 1992; 143:407-415.
4. Easterday BC. Rift Valley fever. Adv Vet Sci 1965;10:65-127.
5. Meslin F-X. Report of lhe WHO/IZSTe consultation on recent developments in Rift Valley fever (with the participation of FAO and OIE). Civitella del Tronto 1993;1-23.
6. Caplen H, Peters CJ, Bishop DHL. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 1985;66:2271-2277.
7. Morrill JC, Jennings GB, Caplen H, et al. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 1987;48:1042-1047.
8. Morrill JC, Carpenter L, Dalrymple J, et al. Further evaluation of ZH-548 strain MP12 as a live attenuated Rift Valley fever vaccine for sheep. Vaccine 1991;9:35-41.
9. Hubbard KA, Baskerville A, Stephenson JR. Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever. Am J Vet Res 1991;52:50-55.
10. Peters CJ, Anderson GW Jr. Pathogenesis of Rift Valley fever. In: Klingsberg MA, ed. Contributions to epidemiology and biostatistics. Vol 3. Basel, Switzerland: S Karger Press, 1981;21-41.
11. Centers for Disease Control and National Institute of Health. Biosafety in microbiological and biomedical laboratories. 3rd ed. Washington, DC: US Department of Health and Human Services, Public Health Service, 1993;24-32.
12. Arborio M, Hall WC. Diagnosis of a human case of Rift Valley fever by immunoperoxidase demonstration of antigen in fixed liver tissue. Res Virol 1989;40:165-168.
13. Meegan JM, Yedloutschnig RJ, Peleg BA, et al. Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am J Vet Res 1987;48: 1138-1141.
14. Ksiazek TG, Jouan A, Meegan JM, et al. Rift Valley fever among domestic animals in the recent West African outbreak. Res Virol 1989;140:67-77.
15. Rossi CA, Turell MJ. Characterization of attenuated strains of Rift Valley fever virus. J Gen Virol 1988;69:817-823.
16. Turell MJ, Rossi CA. Potential for mosquito transmission of attenuated strains of Rift Valley fever virus. Am J Trop Med Hyg 1991;44:278-282.
17. Abel Francisco SF, Quigley JD. Serum immunoglobulin concentrations after feeding maternal colostrum or maternal colostrum plus colostral supplement to dairy calves. Am J Vet Res 1993; 54:1051-1054.
18. Tizard I. An introduction to veterinary immunology. 2nd ed. Philadelphia: WB Saunders Co, 1982;165-177.
19. Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J Pathol Bacteriol 1931;34:545-579.
20. Assad F, Davies FG, Eddy GA, et al. The use of veterinary vaccines for prevention and control of Rift Valley fever. Bull WHO 1983;61:261-268.
21. Yedloutschnig RJ, Dardiri AH, Walker JS, et al. Immune response of steers, goats and sheep to inactivated Rift Valley fever vaccine, in Proceedings. Annu Meet US Anim Health Assoc 1979;83: 253-260.
22. Saluzzo JF, Smith JF. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever viras MP-12 vaccine. Vaccine 1990;8:369-375.
23. Peters CJ, Dalrymple JM. Alphaviruses. In: Fields BN, Knipe DM, et al, eds. Virology. New York: Raven Press Ltd, 1990; 713-761.